CrossRef GLP-1 Receptor Agonists Initiation and Risk of Acute Pancreatitis and Pancreatic Cancer: A Real-World Comparative Study Omar Faour, Moheb Boktor, Hanford Yau, Mustafa Kinaan, Ishak A Mansi American Journal of Medicine Open.2025
A comprehensive meta-analysis of eight GLP-1 RA CVOTs revealed several critical findings: 14% reduction in major adverse cardiovascular events (MACE: cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke) [3] 13% reduction in cardiovascular death [3] 10% reduction in all-cause mortality [3] 11% reduction in hospitalization for heart failure [3] Post-hoc analyzes from LEADER and SUSTAIN-6 revealed that cardiovascular benefits extended across the spectrum of body mass index categories, indicating efficacy regardless of baseline weight [2]
doi: 10.1002/BIOF.5520250129 81 KruzelMLBacsiAChoudhuryBSurSBoldoghI
A European multicentric randomized placebo-controlled study evaluated the effectiveness of livoletide (AZP-531), a non-acylated ghrelin analog, in patients with PWS [101]
A clinician's exam combined with imaging or biopsy is the only reliable way to know for certain
Dziki opatentowanej technologii NL-PEPTIDES podwjnych kapsuek, wchanianie skadnikw aktywnych jest skuteczniejsze
